# Dendritic Cell Based Therapy of Malignant Melanoma

> **NCT00197912** · PHASE1,PHASE2 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 25 (actual)

## Conditions studied

- Advanced Melanoma

## Interventions

- **BIOLOGICAL:** tumor antigen loaded autologous dendritic cells

## Key facts

- **NCT ID:** NCT00197912
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2010-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00197912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00197912, "Dendritic Cell Based Therapy of Malignant Melanoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00197912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*